Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation

<p>Radiotherapy is one of the pillars of modern cancer therapy. However, side effects associated with normal tissue toxicity limit the effectiveness of this treatment. It is therefore desirable to develop tumour-specific radiosensitising agents, which can increase tumour cell kill without incr...

Ful tanımlama

Detaylı Bibliyografya
Yazar: Bittner, M
Diğer Yazarlar: Higgins, G
Materyal Türü: Tez
Baskı/Yayın Bilgisi: 2017
_version_ 1826315882042753024
author Bittner, M
author2 Higgins, G
author_facet Higgins, G
Bittner, M
author_sort Bittner, M
collection OXFORD
description <p>Radiotherapy is one of the pillars of modern cancer therapy. However, side effects associated with normal tissue toxicity limit the effectiveness of this treatment. It is therefore desirable to develop tumour-specific radiosensitising agents, which can increase tumour cell kill without increasing the radiosensitivity of the surrounding normal tissue.</p> <p>This project aimed at validating the radiosensitising potential of depletion of the histone acetyltransferase KAT7, and elucidating the underlying mechanism of action. My results showed a radiosensitising effect of KAT7 depletion in seven tumour cell lines. At the same time, a panel of normal tissue cell lines was not radiosensitised. The depletion of KAT7 caused general cell cycle changes, most notably a twofold increase in the proportion of mitotic cells. At the same time, the G2M checkpoint governing entry into mitosis appeared to be impaired. Livecell imaging confirmed a more than threefold increase in mitotic catastrophe following irradiation in KAT7-depleted cells. An oligonucleotide microarray also showed the downregulation of key members of the mitotic pathway, and patient data demonstrated higher expression of KAT7 to be associated with worse prognosis.</p> <p>In summary, this project supports the tumour-specific radiosensitising potential of KAT7 depletion. This novel target for radiosensitisation seems to exert its effects through altering entry into and progression through mitosis.</p>
first_indexed 2024-03-06T19:41:30Z
format Thesis
id oxford-uuid:20d51ca7-b33f-41c7-a094-34bffa517247
institution University of Oxford
last_indexed 2024-12-09T03:34:15Z
publishDate 2017
record_format dspace
spelling oxford-uuid:20d51ca7-b33f-41c7-a094-34bffa5172472024-12-01T17:48:22ZCharacterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisationThesishttp://purl.org/coar/resource_type/c_db06uuid:20d51ca7-b33f-41c7-a094-34bffa517247ORA Deposit2017Bittner, MHiggins, GMcKenna, G<p>Radiotherapy is one of the pillars of modern cancer therapy. However, side effects associated with normal tissue toxicity limit the effectiveness of this treatment. It is therefore desirable to develop tumour-specific radiosensitising agents, which can increase tumour cell kill without increasing the radiosensitivity of the surrounding normal tissue.</p> <p>This project aimed at validating the radiosensitising potential of depletion of the histone acetyltransferase KAT7, and elucidating the underlying mechanism of action. My results showed a radiosensitising effect of KAT7 depletion in seven tumour cell lines. At the same time, a panel of normal tissue cell lines was not radiosensitised. The depletion of KAT7 caused general cell cycle changes, most notably a twofold increase in the proportion of mitotic cells. At the same time, the G2M checkpoint governing entry into mitosis appeared to be impaired. Livecell imaging confirmed a more than threefold increase in mitotic catastrophe following irradiation in KAT7-depleted cells. An oligonucleotide microarray also showed the downregulation of key members of the mitotic pathway, and patient data demonstrated higher expression of KAT7 to be associated with worse prognosis.</p> <p>In summary, this project supports the tumour-specific radiosensitising potential of KAT7 depletion. This novel target for radiosensitisation seems to exert its effects through altering entry into and progression through mitosis.</p>
spellingShingle Bittner, M
Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation
title Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation
title_full Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation
title_fullStr Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation
title_full_unstemmed Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation
title_short Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation
title_sort characterisation of the histone acetyltransferase kat7 as a novel target for radiosensitisation
work_keys_str_mv AT bittnerm characterisationofthehistoneacetyltransferasekat7asanoveltargetforradiosensitisation